Gastroparesis is a debilitating progressive disease that significantly impacts a patient's life with limited and challenging treatments available. Although the pathogenesis is multifactorial, pylorospasm is believed to have a major underlying role. Several therapeutic interventions directed to the pylorus have been developed over the last decade, including intra-pyloric injections of botulinum toxin, transpyloric stenting, and surgical pyloroplasty. All of these treatment options had limited and disappointing results. More recently, gastric peroral endoscopic myotomy (G-POEM) has been reported as a treatment for refractory gastroparesis. In this review article, we provide an overview on gastroparesis with a focus on the therapeutic interventions. In addition, we provide a literature summary and pool analysis of the clinical efficacy, scintigraphic efficacy, and safety profile of all studies that evaluated G-POEM in gastroparesis. Overall, seven studies have reported on the use of G-POEM in gastroparesis, and the pooled analysis of these studies showed a technical success of 100%, with clinical efficacy as assessed by the Gastroparesis Cardinal Symptoms Index of 81.5%, gastric emptying scintigraphy normalization in approximately 55.5% of the cases, perioperative complications in 7.6%, and intraoperative complications in 6.6%. This suggests that G-POEM is a new promising therapeutic intervention for the treatment of gastroparesis with durable effect and limited potential adverse events.
Introduction
Gastroparesis is a chronic debilitating disease defined as a motility disorder of the stomach and characterized by progressive obstructive clinical symptoms along with an objective delay in gastric emptying. The prevalence of idiopathic gastroparesis has been estimated at 37.8 per 100 000 in women and 9.6 per 100 000 in men. 1, 2 Patients with gastroparesis have a reduced quality of life and impaired nutritional status. 3 In addition, a previous study showed an increased incidence of hospitalization related to gastroparesis. 2 There are several causes of gastroparesis, with one of the most common causes being diabetes mellitus (DM). It is estimated that over 50% of patients with DM and upper gastrointestinal symptoms suffer from gastroparesis. 4 Other causes of gastroparesis include idiopathic, postsurgical, neuropathy, myopathy, and systemic vascular collagen diseases.
Unfortunately, gastroparesis only modestly responds to dietary modification and pro-kinetic medical treatments such as metoclopramide, domperidone, and erythromycin. 5, 6 Furthermore, medical therapy is associated with intolerable and, in some instances, severe adverse events, as well as a tachyphylaxis phenomenon. [7] [8] [9] Given the low therapeutic efficacy of medical treatment, mini-surgical interventional procedures have been used in gastroparesis including gastric electrical stimulation, botulinum toxin intramuscular pyloric injections, endoscopic transpyloric stent placement, laparoscopic pyloroplasty, gastrostomy tube insertion, and even gastrectomy (for patients with refractory symptoms). [10] [11] [12] [13] Notably, in recent years, a minimally invasive surgical procedure, named gastric peroral endoscopic myotomy (G-POEM), was introduced in clinical practice with the goal of dissecting the muscular layer in the pylorus.
14 During G-POEM, a pyloric submucosal tunnel is created followed by dissection myotomy similar to the principle used in treatment of achalasia. 15 After the first report of G-POEM in gastroparesis by Khashab et al., 14 several case series and studies have since followed. We provide an updated review on gastroparesis with a focus on the role of G-POEM in its treatment, including a summary of the available data reported in the literature.
Pathophysiology of gastroparesis
The mechanism of gastric motility is complex and not fully understood. Some identified factors that can contribute to gastric dysmotility include vagal and sympathetic nerve dysfunction. Although no predominant underlying cause has been identified, the pylorus structure is the main modifier of gastric emptying. In a state of gastroparesis, the pylorus is believed to be the obstacle for passage of the food bolus from stomach to duodenum. An earlier study reported that almost 60% of diabetics show evidence of vigorous pyloric contractions termed pylorospasm. 16 The enteric nervous system, composed of the interstitial cells of Cajal (ICCs) that are considered the pacemakers of the gastric body, are lost in gastroparesis. This may result in impaired fundic accommodation, antral hypomotility, gastric dysrhythmias, and pyloric compliance. 5 It is yet undetermined whether ICC loss is the predominant underlying mechanism involved in gastroparesis or if there are other contributing factors in this disorder. An additional study reported that the mechanism of diabetic and idiopathic gastroparesis is diffuse loss of ICCs as assessed by full thickness gastric biopsies. 17 While most data support ICC dysfunction as a cause of gastroparesis, other studies support parasympathetic dysfunction and vagus nerve injury as an underlying factor in the pathogenesis of gastroparesis, especially in DM. Because vagus nerve stimulation mediates pyloric relaxation and facilitates food bolus passage to the duodenum, injury of this nerve is associated with decreased pyloric relaxation and the appearance of obstructive symptoms characteristic of gastroparesis. Recently, another proposed pathomechanism for gastroparesis that has been suggested involves defective or decreased nitric oxide synthesis and release, which is similar to the depletion that was well-identified in achalasia patients causing impaired relaxation of the lower esophageal sphincter. 18 
Treatment options for gastroparesis
Given the fundamental role of the pylorus in the pathogenesis of gastroparesis, several treatment options target the pyloric level. These treatments are designed to alleviate the obstructive pylorus, or so-called persistent pylorospasm, without affecting the remaining pyloric musculature providing consequent relief of the clinical manifestations of gastroparesis. These treatment modalities include balloon dilation, stent insertion, botulinum toxin A injection, gastric electrical stimulation, surgical pyloroplasty/ pyloromyotomy, gastrostomy, gastrectomy, and more recently G-POEM. All of these interventions have been evaluated in clinical trials with variable results. Some interventions were only modestly effective while others failed to show efficacy without clear quality of life benefit. In fact, inter-pyloric injection of botulinum toxin has failed to show efficacy in randomized trials. [19] [20] [21] [22] Similarly, results of endoscopic stenting 23 were disappointing. On the other hand, gastric electrical stimulation showed good efficacy, [24] [25] [26] and LP was effective in the treatment of gastroparesis, but it was associated with technical complications. 11 Miller et al. reported a series of 10 patients with idiopathic gastroparesis who did not respond to pro-kinetic agents and were treated with (80-100 units) of botulinum toxin injected directly into the pyloric sphincter. They showed a significant decrease in the gastric retention percent of solid contents at 4 h from approximately 27 (normal <10%) to 14% after intervention (P = 0.038). Moreover, the clinical symptom score significantly improved at 4 weeks. Three out of the 10 patients had no response. Furthermore, among those who responded initially, symptom improvement was maintained even at 6 months. 27 In another study, only short-term symptomatic relief was observed with 20-mm pyloric balloon dilation. 28 Recently, another new technique was implemented in the treatment of gastroparesis called laparoscopic pyloroplasty (LP). A classical LP procedure involves longitudinal dissection through the muscle layer of the distal antrum and proximal duodenum. Shada et al. collected and analyzed the data of 177 patients after LP over 5 years and noted an improvement in 86% of patients with gastroparesis with symptomatic resolution in 77% of patients. There were no intraoperative complications related to the LP procedure and no conversion to open surgery. However, four patients were operated on again and two patients were diagnosed with a leak. 29 Moreover, Heckert et al. reported a prospective effectiveness analysis of 151 patients with refractory gastroparesis who were treated with gastric electrical stimulation and found that 75% had improved symptoms, as nausea, early satiety, and loss of appetite were the most common symptoms to respond to gastric electrical stimulation. 30 Another treatment method involving transpyloric stent insertion in 30 patients with refractory gastroparesis was reported by Khashab et al. Technical success was achieved in 98% of patients, and clinical relief was achieved in 75% of patients. When evaluated by symptoms, greater success was achieved in those with predominant nausea and vomiting. Nearly 50% of the patients had stent migration, and 31 thus, the limitation of this technique includes potential for stent migration and loss of long-term efficacy. Given the potential of pyloric interventions for improving symptoms and gastric emptying, a simple minimally invasive approach for cutting the pylorus would be highly desirable and likely effective long term.
Methods
We performed a MEDLINE/PubMed search for gastroparesis, delayed gastric emptying, treatment of gastroparesis, G-POEM, gastric peroral myotomy, endoscopic treatment of gastroparesis, and pyloromyotomy. A total of seven relevant studies were identified, and abstracts were examined. The studies included case series, retrospective studies, and prospective studies. Of note, the main limitation is that it was unclear to the authors whether part of the patient's cohort reported by Kahaleh et al. 32 were previously reported by Gonzales et al., 33 because those studies were conducted by the same group. Thus, this issue might change the pooled analysis.
Gastric peroral endoscopic myotomy
The G-POEM procedure is performed in many aspects like that used for achalasia and is based on submucosal dissection and pyloric dissection. Technically, the patient is usually placed in left lateral decubitus position and should be given prophylactic intravenous antibiotics at the start of the G-POEM. The procedure is carried out with a gastroscope fitted with a transparent cap and insufflation, preferably with carbon dioxide. In G-POEM, the length of myotomy is usually shorter than that used in achalasia given that the pylorus is usually a well-defined anatomical area of smooth muscle that is not as long as that of the lower esophageal sphincter. The length of the myotomy, therefore, is generally short and ranges between 1.5 and 2 cm in most case series. 34 Other technical methods used in G-POEM are beyond the scope of this review.
Evidence through literature
Since the first report on G-POEM in a refractory case of gastroparesis in 2013, 14 several reports followed. In a review of the literature, there are up to 144 patients reported with several retrospective and case series studies assessing the use of G-POEM for refractory gastroparesis. Pooled analysis of the studies included in this review showed 100% technical success, with clinical efficacy as assessed by the Gastroparesis Cardinal Symptoms Index (GCSI) of 81.5%, gastric emptying scintigraphy (GES) normalization in approximately 55.5% of the cases, perioperative complications in 7.6%, and intraoperative complications in 6.6% (Table 1) .
Shlomovitz et al. reported G-POEM in seven female patients, and in all patients, the procedure was reported as technically successful with six out of seven achieving significant clinical improvement. At the 3-month follow-up, four out of the five patients in whom data was available had normal gastric emptying at 4 h, and one patient underwent subsequent laparoscopic pyloroplasty after failed G-POEM. There were no intra-procedural or immediate complications reported, but reported late complications included upper GI bleed at 2 weeks, dysphagia, and hospital acquired pneumonia. 35 Recently, several larger retrospective studies and one prospective study were published. Khashab et al. reported the first multicenter non-randomized study at five medical centers in patients with refractory gastroparesis assessing the efficacy and safety of G-POEM as compared with medical therapy. Of the 30 patients included (11 diabetic, 12 postsurgical, and 7 idiopathic), G-POEM was reported as technically successful in all patients. Technical details of the procedure included mean procedure time of 72 min and mean myotomy length of 2.6 +/ À 2.3 cm. At follow-up of greater than 5 months, complete symptomatic improvement was seen in 86% of patients. Adverse events included capno-peritoneum and prepyloric ulcer in one patient each. 36 An additional relatively large case series was reported on a total of 47 patients with gastric emptying confirmed gastroparesis, and of whom, approximately just over 50% had idiopathic gastroparesis, approximately 25% had diabetic gastroparesis, and 17% had postsurgical gastroparesis. Additionally, approximately 87% of patients had at least one previous pyloric intervention including botulinum injection, electrical gastric stimulation, and feeding tube insertion. The average gastric retention percent of ingested food bolus was significantly decreased following the G-POEM procedure, and similarly, the GCSI Table 1 Summary of the studies reported on gastric peroral endoscopic myotomy in gastroparesis Reference Shlomovitz et al. 35 Khashab et al. 36 Rodriguez et al. 37 Gonzalez et al. 33 Malik et al. 40 Mekaroonkamol et al. 41 Kahaleh et al. 32 Pooled GCSI, Gastroparesis Cardinal Symptoms Index; GES, gastric emptying scintigraphy.
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Endoscopic pyloromyotomy in gastroparesis significantly improved. Of note, in this series, one patient died within 1 month of their index procedure, which was reported to be unrelated to the procedure. 37 Gonzalez et al. recently reported a single center experience of 29 patients who underwent G-POEM. Technically, the procedure was successfully completed in all patients, and 79% achieved complete clinical improvement at 3 months and 69% at 6 months. Gastric emptying studies normalized in 70% of cases where the information was available and adverse events occurred in two patients (mild bleeding and both treated conservatively). Risk factors for G-POEM failure were female gender and diabetic gastroparesis as seen by univariate analysis; however, this finding was not reproduced in multivariate analysis. The study authors hypothesized that there was a lower response in diabetic patients as compared with idiopathic and postoperative gastroparesis because diabetes may affect the rest of the gastrointestinal tract in addition to the stomach leading to a lower degree of response. 33 In another retrospective study conducted at a tertiary referral center, Dacha et al. retrospectively reviewed 16 patients (three of them were reported earlier by Mekaroonkamol et al. 38 ) who underwent G-POEM and found that GCSI significantly improved post procedure in 81% of patients. Furthermore, there was significant improvement in quality of life as well as in the gastric emptying study post procedure with no adverse events reported. 39 Recently, few studies have been published. Malik et al. reported 13 patients who underwent G-POEM for refractory gastroparesis (one diabetic, four idiopathic, and eight postsurgical) with clinical and GES improvement occurring in 73% and 67% respectively and GES normalization in 33% of patients. 40 Mekaroonkamol et al. 41 reported 30 patients with refractory gastroparesis who underwent G-POEM (some patients reported by Mekaroonkamol et al. were reported earlier by the same group, by Dacha et al. 39 ). The technical success reached 100% coupled with significant symptomatic improvement as assessed by GCSI (P < 0.0005), statistically significant reduction in hospitalization related to gastroparesis (P = 0.0002), and improved quality of life (P < 0.0005). 41 Moreover, Kahaleh et al. reported an international multicenter study on 33 patients with gastroparesis. Technical success was achieved in 100%, symptomatic improvement as assessed by GCSI was seen in 85%, with GCSI score improved from 3.3 at baseline to 0.8 post-treatment (P < 0.001) with significant improvement in GES (P < 0.001). 32 Nonetheless, there is still controversy regarding whether to use the greater or lesser curvature myotomy technique. More importantly, the decision regarding candidacy for G-POEM is still in question. Thus, evaluation of the underlying pathophysiology (in particular pyloric function) should be added in future studies about G-POEM, in order to identify the best candidates for this procedure.
Conclusions
Gastric peroral endoscopic myotomy is a promising and revolutionary interventional endoscopic procedure for treatment of the debilitating condition of gastroparesis. This emerging technique has recently been widely described with overall excellent technical success coupled with a high safety profile and potentially beneficial therapeutic effect. Endoscopic pyloric interventions for gastroparesis seem to hold tremendous promise including the ability to normalize GES in a substantial proportion of patients, thus significantly improving a patient's quality of life. Given the low therapeutic yield of the other medically and minimally invasive described techniques available as treatment options for gastroparesis, we assume that G-POEM will rapidly evolve into one of the first-line recommended treatment options for patients with refractory gastroparesis following dietary and medical treatment failure. Well-designed, randomized trials, and international prospective studies with clinically relevant endpoints (including evaluation and assessment of the underlying pathophysiology) are required and particularly in patients with refractory gastroparesis. In addition, head-to-head randomized controlled trials are further needed to help establish guideline recommendations for stepwise management of gastroparesis.
